Flea-borne typhus EO 14398

Active Awarded Last action

Contract number
75D30126F21487
Awardee
Awarding agency
Obligated
$29,956

Award facts

Opportunity
  • 75D30126Q79212 Solicitation number
Contract value 100% obligated
$29,956.00 Current and potential, with all options
Completion date 15% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Secaucus, NJ 07094, USA

Award details come from SAM.gov/FPDS.

About this award

The Centers for Disease Control and Prevention issued a $29,956 delivery order to Quest Diagnostics Incorporated on August 28, 2026, under the GSA Medical Laboratory Testing and Analysis Services schedule (FSS-621-II) for flea-borne typhus testing services.

The order carries a firm fixed price and is not set-aside. Place of performance is Secaucus, NJ. Period of performance extends through August 27, 2027.

Quick answers

Who was awarded contract 75D30126F21487?

75D30126F21487 was awarded to Quest Diagnostics Incorporated by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 28, 2026.

How much is contract 75D30126F21487 worth?

The government has obligated $29,956 on 75D30126F21487.

Is contract 75D30126F21487 an order under another contract?

Yes. 75D30126F21487 is a delivery order under V797D70090, a federal supply schedule, on Medical Laboratory Testing and Analysis Services (FSS-621-II).

Was contract 75D30126F21487 competed?

The extent of competition for 75D30126F21487 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award